We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-20.00 | -1.02% | 1,934.00 | 1,925.00 | 1,926.00 | 1,956.00 | 1,919.00 | 1,955.00 | 145,039 | 16:35:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8653 | 22.25 | 4.34B |
Date | Subject | Author | Discuss |
---|---|---|---|
05/5/2022 15:36 | P/E ~ 11 for a pharmaceutical company with a solid balance sheet with growth areas seems very low. | justiceforthemany | |
05/5/2022 12:21 | Wrong yet again Monty I must say you are a very useful contra bellwether | phillis | |
05/5/2022 10:53 | 10% share price fall seems very harsh for these revenues moving out perhaps 2-3 months! | adamb1978 | |
05/5/2022 10:02 | Serial disappointment. The last one was About the GSK drug thingee.The CEO is well regarded so we'll see what happens | robertball | |
05/5/2022 08:39 | Market always overdo it on the downside and upside.Like I said never ever thought I would see forecast p.e 10.7 for Hikma. | montyhedge | |
05/5/2022 08:25 | While sentiment is generally against this stock, any little wobble will knock the price down far more than an equivalent bit of good news will raise it. Sentiment will turn whenever it deigns to. | mjneish | |
05/5/2022 08:24 | Looks to be a bit of a timing issue - so imo the fall looks overly harsh. But who knows - this share has been hammered since the end of last year. Suet | suetballs | |
05/5/2022 08:07 | Cant fall much further surely | scepticalinvestor | |
05/5/2022 08:07 | Added at 1660 | scepticalinvestor | |
05/5/2022 08:01 | Not really | robertball | |
05/5/2022 07:53 | Good grief, basket case | scepticalinvestor | |
05/5/2022 07:08 | Never thought I would see Hikma forecast p.e 10.7. Well at least more shares for them in the buybacks. | montyhedge | |
05/5/2022 07:07 | The FT just said that share price subdues due to slow generics. | robertball | |
05/5/2022 06:53 | Nope sorry that was wrong It was unchanged | netcurtains | |
05/5/2022 06:46 | Lower generics guidance for 2022 this am - not good with the share price already severely depressed. Suet | suetballs | |
04/5/2022 07:25 | Do we know the reason for recent big falls? What did the FT comment say? Thanks for any info. Cheers Net. | netcurtains | |
30/4/2022 07:06 | As per FT comment today | robertball | |
29/4/2022 15:20 | Monty: Thanks for pointing that out. Cheers Net! | netcurtains | |
29/4/2022 14:23 | It will bounce, in April 2020 shares were 1767p April 2020 trading update said generic margins 13% to 18% shares were 2700p by the Oct 2020.This April trading update generic margins 23% to 25% growth 8% to 9% and shares fall 7.2%. | montyhedge | |
29/4/2022 13:10 | blue59: Well, if you know different, you're not telling anyone. I suspect no one actually knows. It will probably either recover quickly (as it has in the past) or some further news will come out explaining it all. | netcurtains | |
29/4/2022 12:37 | Down 7%, I thought quite good, they said strong cash generation. All in line, shows how much I know, lol | montyhedge | |
29/4/2022 10:16 | Must admit seems strange, unless a fund dumping, but look at the shares in the buyback 100p cheaper. | montyhedge | |
29/4/2022 10:05 | Was it just a HIK up? | netcurtains | |
29/4/2022 08:02 | Why is a PE ratio of about 12, with a dividend, with share buyback, and growing at 7% per annum considered bad news? What have I missed? | netcurtains |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions